Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C H Functionalization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel 3-step route for kinase inhibitor intermediates eliminates high-pressure CO. Enhances safety and scalability for reliable pharmaceutical supply chains.
Novel synthesis of anticancer annonaceolide analogs via simplified polyether chains. Cost-effective route for high-purity pharmaceutical intermediates.
Novel acid-catalyzed method reduces aldehyde usage and eliminates metal catalysts for cost-effective manufacturing.
Patent CN113845466A details a mild hypervalent iodine-mediated alpha-oxidation for producing high-purity pharmaceutical intermediates with improved yield and environmental profile.
Patent CN115613061A reveals a green electro-catalytic method for azide-substituted tetrazolo[1,5-a]indole synthesis, offering cost-effective scale-up for pharmaceutical intermediates.
Patent CN112851670A reveals a green photocatalytic route for fluorinated heterocycles, offering cost reduction and high purity for pharmaceutical intermediate manufacturing.
Patent CN111592549B reveals a novel Rh-catalyzed [4+1] cyclization for quinazolinone derivatives, offering streamlined synthesis and cost reduction in API manufacturing.
Patent CN110330475A reveals mild carbocation-mediated synthesis. Enables cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Patent CN109824665B details a novel oxidative coupling method for synthesizing imidazopyridine sulfonamides using methanol, offering cost-effective routes for pharmaceutical intermediates.
Patent CN112979545B reveals a metal-free route to 5-selenoquinolines using PIFA. This method offers high regioselectivity and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN110204491B details a novel Pd-catalyzed asymmetric C-H functionalization route for chiral 3,4-dihydroisoquinolinones, offering superior selectivity and cost efficiency for pharmaceutical manufacturing.
Novel Pd-catalyzed C-H bifunctionalization for nitrogen heterocycles. Enhances purity and supply chain reliability for pharma intermediates.
Patent CN103641879A details a novel chemical route for prednisolone intermediates using plant sterols, offering significant cost reduction and high purity for pharmaceutical manufacturing.
Patent CN110642752A discloses a Pd-catalyzed selective alkenylation method yielding 45-98%, offering cost-effective routes for complex API intermediates and natural products.
Patent CN110922350B reveals a green, metal-free route for C2-acyloxylation of oxindoles using KI/H2O2, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN115557900A details a mild Rh-catalyzed route to 3-substituted pyridazines with quaternary centers, offering high efficiency for reliable pharmaceutical intermediate suppliers.
Patent CN108033922B reveals a metal-free radical acylation method for 3-acyl quinoxalinones. Achieve high purity and cost reduction in API manufacturing with this green technology.
Patent CN102731386B reveals a novel Pd-catalyzed route for secondary diimides, offering neutral conditions and cost reduction in API manufacturing for global supply chains.
Patent CN106831474B details a rhodium-catalyzed synthesis of alpha-aryl-alpha,beta-diamino acid esters with high selectivity for anticancer drug manufacturing.
Patent CN109721590B details a novel cobalt-catalyzed method for C2 alpha acyloxy indole synthesis, offering cost reduction and improved regioselectivity for pharmaceutical intermediate manufacturing.